Ayahuasca or esketamine: which eases depression better?
NCT ID NCT07212946
First seen Jun 27, 2026 · Last updated Jun 27, 2026
Summary
This study tested whether four weekly doses of ayahuasca (a plant-based psychedelic drink) or esketamine (a nasal spray) could reduce symptoms in 22 adults with severe major depression. Participants were randomly assigned to one treatment, and their depression levels were tracked using a standard questionnaire. The goal was to see which approach works better for easing depression.
This is an AI summary of the original study and may miss details. Read our disclaimer.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for MAJOR DEPRESSION SEVERE are added.
By submitting, you agree to our Terms of use
Conditions
The condition(s) this trial relates to.
As listed by the trial registrant
The condition terms exactly as the trial's registrant entered them.
Contacts and locations
Locations
-
Hospital das Clínicas da FMRP-USP
Ribeirão Preto, São Paulo, 14049900, Brazil
More trials for these conditions
Other studies related to the condition(s) this trial covers.